Ewing sarcoma: Difference between revisions

Line 19: Line 19:


==Differential Diagnosis==
==Differential Diagnosis==
===Malignant===
*[[Multiple myeloma]]
*[[Chondrosarcoma]]
*[[Paget disease]]
*[[Osteosarcoma]]
*[[Giant cell tumor]]
*[[Adamantinoma]]
*[[Chordoma]]
*[[Primary bone lymphoma]]
*Fibrosarcoma
*Myosarcoma
*[[Abscess]]


===Benign===
*[[Chrondroblastoma]]
*[[Enchondroma]]
*[[Langerhans cell histiocytosis of bone]]
*[[Osteoblastoma]]
*[[Osteochondroma]]
*[[Osteoid Osteoma]]


==Evaluation==
==Evaluation==

Revision as of 22:37, 21 November 2019

Background

  • Highly aggressive malignant bone or soft tissue tumor arising from cells of the neuroectoderm
  • One-fourth of patients will have metastasis at the time of presentation
    • It is assumed that almost all patients have subclinical metastasis
  • Presence and location of metastasis is the major prognostic factor for survival
  • Metastasis is most frequently seen in bone (spine most common) and lungs
  • Around 70 to 80 percent survival in those with non-metastatic disease
  • More common in males

Clinical Features

  • Constant pain for months over site of malignancy
    • Worse with exercise and at night
  • Site will be edematous and tender to palpation
    • Mass can sometimes be appreciated
  • Most often found in pelvis, axial skeleton, or diaphysis of femur with a small minority arising in soft tissues
  • Pelvic tumors are more regularly associated with metastatic disease
  • Fever, weight loss, fatigue, night sweats occur in less than 20 percent of patients
  • Pathological fractures can occur

Differential Diagnosis

Malignant

Benign

Evaluation

Management

Disposition

References